AzTrials
AzTrials

Healthcare Workforce Well-BeingNCT07791563

Digital Intervention for Healthcare Workers

A study testing Engage and HCW-Tailored Engage in people with Healthcare Workforce Well-Being, run by University of Illinois at Chicago at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to test which engagement strategies lead to more participation in a digital mental health program among healthcare workers. The main questions it aims to answer is: Does content tailoring increase engagement with the digital program? Does human support increase engagement with the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Healthcare Workforce Well-Being
What is being tested?
Engage and HCW-Tailored Engage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
201 participants
Where
1 siteUnited States
Study dates
Nov 2026to Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older, all sexes
  • Currently working in healthcare in the US with at least 4 hours per week of direct patient contact
  • Stable access to internet
  • Have a total score between 3-14 on the PHQ-9 (Patient Health Questionnaire-9), suggestive of mild to moderate depressive symptoms

Who cannot join

  • Have a total score of ≥15 on the PHQ-9, indicating Severe Depressive symptoms.
  • Currently diagnosed with a psychotic disorder or bipolar disorder, based on self-report.
  • Currently receiving psychotherapy for depression or anxiety based on self-report; If on medications for depression or anxiety, must be on a stable dose of medication for at least 2 weeks.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jennifer Duffecy, PhD contact

312-413-1225

jduffecy@uic.edu

United States1 site
  • Neuropsychiatric Institute

    Chicago, Illinois, 60612

    Jennifer Duffecy, PhD, 312-413-1225, jduffecy@uic.edu

Other trials in United States

About this study

Official title: Enhancing Sustained Engagement in Digital Mental Health Interventions (DMHIs)

The goal of this clinical trial is to test which engagement strategies lead to more participation in a digital mental health program among healthcare workers. The main questions it aims to answer is:

  • Does content tailoring increase engagement with the digital program?
  • Does human support increase engagement with the digital program?
Read more

Researchers will compare the general intervention to a tailored intervention and to the tailored intervention with human support coaching to see what leads to more engagement with/use of the program.

Participants will:

  • Use a digital program weekly for 6 weeks
  • Complete questionnaires at 5 times: Start of study, Week 2, Week 3 (mid-program), Week 6 (end of program), and Week 10 (follow-up)
Being tested
Engage, HCW-Tailored Engage
Keywords
digital mental health interventions, engagement, healthcare workers

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EngageBehavioural

    The digital mental health intervention is based on Cognitive Behavioral Therapy principles and consists of learning modules covering basic skills (e.g., behavioral activation) and interactive tools to assist in learning and implementing the skills associated with the learning modules. Interactive tools are designed to support implementation of cognitive behavioral skills including activity scheduling and monitoring, cognitive restructuring, goal setting, relaxation, and mood tracking.

  • HCW-Tailored EngageBehavioural

    The digital mental health intervention is based on Cognitive Behavioral Therapy principles and consists of learning modules covering basic skills (e.g., behavioral activation) and interactive tools to assist in learning and implementing the skills associated with the learning modules. Interactive tools are designed to support implementation of cognitive behavioral skills including activity scheduling and monitoring, cognitive restructuring, goal setting, relaxation, and mood tracking. This version of the intervention contains content tailored specifically for healthcare workers, based on findings from a co-design, qualitative focus group process.

Study groups in NCT07791563
Study groupRoleWhat they receive
Control GroupActive comparatorInfographic onboarding and the Cognitive Behavioral Therapy (CBT)-based 6-week digital mental health intervention.
Receives: Behavioral: Engage
Content Tailoring GroupExperimentalHealthcare-worker-tailored infographic onboarding and the Cognitive Behavioral Therapy (CBT)-based 6-week digital mental health intervention with healthcare worker tailoring.
Receives: Behavioral: HCW-Tailored Engage
Content Tailoring Plus Human Support GroupExperimentalAn onboarding engagement call with a human coach and the Cognitive Behavioral Therapy (CBT)-based 6-week digital mental health intervention with healthcare worker tailoring, plus human support via messaging (coaching).
Receives: Behavioral: HCW-Tailored Engage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Engagement with the intervention (subjective)

    The primary outcome is engagement with intervention. Subjective engagement will be measured via the TWente Engagement with Ehealth Technologies Scale (TWEETS), a 9-item measure aimed at assessing behavioral engagement, cognitive engagement, and affective engagement. A higher total score reflects a greater, more positive engagement with the digital health intervention.

    Measured: From start of intervention to end of intervention period at 6 weeks.

  2. Engagement - Number of Lessons

    An objective measure of engagement with the digital intervention is number of lessons read (i.e., module completion). More lessons read reflects more engagement with the intervention.

    Measured: From start of intervention to end of intervention period at 6 weeks.

  3. Engagement - Number of Tools

    An objective measure of engagement with the digital intervention is number of tools completed (i.e., tool usage). More tools completed reflects more engagement with the intervention.

    Measured: From start of intervention to end of intervention period at 6 weeks.

  4. Engagement - Duration of Time

    An objective measure of engagement with the digital intervention is the duration of time participants spend on the digital intervention site. More time on the site reflects more engagement with the intervention.

    Measured: From start of intervention to end of intervention period at 6 weeks.

Secondary outcomes (3)
  1. Burnout

    Burnout is measured via the Oldenburg Burnout Inventory, a validated 16-item survey with positively and negatively framed items that cover 2 areas: exhaustion (physical, cognitive, and affective aspects) and disengagement from work (negative attitudes toward work objects, work content, or work in general). Scores on the Oldenburg Burnout Inventory can be presented as an overall total (range 16 to 64). Higher total scores indicate a higher level of burnout.

    Measured: From baseline to follow-up at 10 weeks.

  2. Depressive Symptoms

    Depressive symptoms are measured via the Patient Health Questionnaire (PHQ-9), a validated 9-item multipurpose instrument for screening, monitoring, and measuring depression, asking participants to rate their frequency of DSM symptoms over the past 2 weeks. PHQ-9 scores are obtained by adding score for each question (total points). Total scores of 5, 10, 15, and 20 represent cut-points for mild, moderate, moderately severe and severe depression, respectively. Higher scores reflect more depressive symptoms.

    Measured: From baseline to follow-up at 10 weeks.

  3. Anxiety symptoms

    The Generalized Anxiety Disorder Screener (GAD-7) is a validated 7-item practical self-report anxiety questionnaire, asking participants to rate their frequency of symptoms over the past 2 weeks. GAD-7 score obtained by adding score for each question (total points). Total scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety. Higher scores reflect more anxiety.

    Measured: From baseline to follow-up at 10 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2026
  2. Study startNov 2026 (estimated)
  3. Primary completionJan 2028 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
201 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07791563
Sponsor's protocol ID
2025-0594
Other IDs
UM1TR005438
Status last verified
Aug 2026
First submitted
24 Aug 2026
Last updated
28 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Engage and HCW-Tailored Engage in people with Healthcare Workforce Well-Being, run by University of Illinois at Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jennifer Duffecy, PhD (312-413-1225, jduffecy@uic.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Engagement with the intervention (subjective) (time frame: From start of intervention to end of intervention period at 6 weeks.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in